Farther Finance Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Farther Finance Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-350	Closed	-$865	–	4145
2024 Q2	$865	Buy	+350	New	+$1.34K	﹤0.01%	3119

Farther Finance Advisors's GTHX Position: Q3 2024 in Review

Farther Finance Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 350 shares — an estimated $865 sold.

Farther Finance Advisors first reported a position in GTHX in Q2 2024 and held it in 1 quarter. The position peaked at $865 in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Farther Finance Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Farther Finance Advisors sold 350 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $865.
Farther Finance Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Farther Finance Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $865 in Q2 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Farther Finance Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.